JOYA CHANDRA to Leukemia, Lymphocytic, Chronic, B-Cell
This is a "connection" page, showing publications JOYA CHANDRA has written about Leukemia, Lymphocytic, Chronic, B-Cell.
Connection Strength
0.396
-
Caspase-8 dependent histone acetylation by a novel proteasome inhibitor, NPI-0052: a mechanism for synergy in leukemia cells. Blood. 2009 Apr 30; 113(18):4289-99.
Score: 0.135
-
Protease activation and glucocorticoid-induced apoptosis in chronic lymphocytic leukemia. Leuk Lymphoma. 1999 May; 33(5-6):421-31.
Score: 0.068
-
Proteasome inhibitors induce apoptosis in glucocorticoid-resistant chronic lymphocytic leukemic lymphocytes. Blood. 1998 Dec 01; 92(11):4220-9.
Score: 0.067
-
Protease activation is required for glucocorticoid-induced apoptosis in chronic lymphocytic leukemic lymphocytes. Blood. 1997 Nov 01; 90(9):3673-81.
Score: 0.062
-
The proteasome inhibitor NPI-0052 is a more effective inducer of apoptosis than bortezomib in lymphocytes from patients with chronic lymphocytic leukemia. Mol Cancer Ther. 2006 Jul; 5(7):1836-43.
Score: 0.028
-
Involvement of reactive oxygen species in adaphostin-induced cytotoxicity in human leukemia cells. Blood. 2003 Dec 15; 102(13):4512-9.
Score: 0.023
-
Apoptosis sensitivity in chronic lymphocytic leukemia is determined by endogenous endonuclease content and relative expression of BCL-2 and BAX. J Immunol. 1996 Apr 01; 156(7):2624-30.
Score: 0.014